Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study von RAWSTRON, Andy C, CHILD, J. Anthony, ROSS, Fiona M, COOK, Gordon, JACKSON, Graham H, MORGAN, Gareth J, OWEN, Roger G, DE TUTE, Ruth M, DAVIES, Faith E, GREGORY, Walter M, BELL, Sue E, SZUBERT, Alexander J, NAVARRO-COY, Nuria, DRAYSON, Mark T, FEYLER, Sylvia

Volltext

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial von Morgan, Gareth J, Dr, Prof, Davies, Faith E, MD, Gregory, Walter M, Prof, Cocks, Kim, MSc, Bell, Sue E, DPhil, Szubert, Alex J, MSc, Navarro-Coy, Nuria, MPhil, Drayson, Mark T, MD, Owen, Roger G, MD, Feyler, Sylvia, MD, Ashcroft, A John, MD, Ross, Fiona, DPhil, Byrne, Jennifer, MD, Roddie, Huw, MD, Rudin, Claudius, MD, Cook, Gordon, MD, Jackson, Graham H, Prof, Child, J Anthony, Prof

Volltext

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells von EL-SHERBINY, Yasser M, MEADE, Josephine L, MORGAN, Gareth J, COOK, Graham P, HOLMES, Tim D, MCGONAGLE, Dennis, MACKIE, Sarah L, MORGAN, Ann W, COOK, Gordon, FEYLER, Sylvia, RICHARDS, Stephen J, DAVIES, Faith E

Volltext

Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent von Feyler, Sylvia, Scott, Gina B, Parrish, Christopher, Jarmin, Sarah, Evans, Paul, Short, Mike, McKinley, Katherine, Selby, Peter J, Cook, Gordon

Volltext

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised cont... von Morgan, Gareth J, Prof, Child, J Anthony, Prof, Gregory, Walter M, Prof, Szubert, Alex J, MSc, Cocks, Kim, MSc, Bell, Sue E, DPhil, Navarro-Coy, Nuria, MPhil, Drayson, Mark T, MD, Owen, Roger G, MD, Feyler, Sylvia, MD, Ashcroft, A John, MD, Ross, Fiona M, DPhil, Byrne, Jennifer, MD, Roddie, Huw, MD, Rudin, Claudius, MD, Cook, Gordon, MD, Jackson, Graham H, Prof, Wu, Ping, MSc, Davies, Faith E, MD

Volltext

Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic von Carmichael, Jonathan, Seymour, Frances, McIlroy, Graham, Tayabali, Sarrah, Amerikanou, Rosie, Feyler, Sylvia, Popat, Rakesh, Pratt, Guy, Parrish, Christopher, Ashcroft, A. John, Jackson, Graham H., Cook, Gordon

Volltext

Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM) von Feyler, Sylvia, Selby, Peter J, Cook, Gordon

Volltext

Guidelines for the diagnosis and management of multiple myeloma 2011 von BIRD, Jennifer M, OWEN, Roger G, MORGAN, Gareth, CAVENAGH, Jamie, LOW, Eric, BEHRENS, Judith, D'SA, Shirley, SNOWDEN, John A, PRATT, Guy, ASHCROFT, John, YONG, Kwee, COOK, Gordon, FEYLER, Sylvia, DAVIES, Faith

Volltext

Guidelines for supportive care in multiple myeloma 2011 von Snowden, John A., Ahmedzai, Sam H., Ashcroft, John, D’Sa, Shirley, Littlewood, Timothy, Low, Eric, Lucraft, Helen, Maclean, Rhona, Feyler, Sylvia, Pratt, Guy, Bird, Jennifer M.

Volltext

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma I... von MORGAN, Gareth J, DAVIES, Faith E, DRAYSON, Mark T, OWEN, Roger G, ROSS, Fiona M, RUSSELL, Nigel H, JACKSON, Graham H, CHILD, J. Anthony, GREGORY, Walter M, BELL, Sue E, SZUBERT, Alexander J, NAVARRO COY, Nuria, COOK, Gordon, FEYLER, Sylvia, JOHNSON, Peter R. E, RUDIN, Claudius

Volltext

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation von Morgan, Gareth J., Davies, Faith E., Gregory, Walter M., Russell, Nigel H., Bell, Sue E., Szubert, Alexander J., Coy, Nuria Navarro, Cook, Gordon, Feyler, Sylvia, Byrne, Jenny L., Roddie, Huw, Rudin, Claudius, Drayson, Mark T., Owen, Roger G., Ross, Fiona M., Jackson, Graham H., Child, J. Anthony

Volltext

CD4+CD25+FoxP3+ regulatory T cells are increased whilst CD3+CD4-CD8- alpha beta TCR+ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma... von Feyler, Sylvia, von Lilienfeld-Toal, Marie, Jarmin, Sarah, Marles, Lee, Rawstron, Andy, Ashcroft, A J, Owen, Roger G, Selby, Peter J, Cook, Gordon

Volltext

Reduced Circulating Memory B-Cells Account for Humoral Immune Defects in Multiple Myeloma, Associated with Infective Risk and Poor Vaccination Responses von Carmichael, Jonathan, Carter, Clive R, Parrish, Christopher, Kallmeyer, Charlotte, Feyler, Sylvia, Wood, Philip M., Cook, Gordon

Volltext

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research von Smith, Alexandra, Roman, Eve, Howell, Debra, Jones, Richard, Patmore, Russell, Jack, Andrew

Volltext

Updates to the guidelines for the diagnosis and management of multiple myeloma von Pratt, Guy, Jenner, Matthew, Owen, Roger, Snowden, John A., Ashcroft, John, Yong, Kwee, Feyler, Sylvia, Morgan, Gareth, Cavenagh, Jamie, Cook, Gordon, Low, Eric, Stern, Simon, Behrens, Judith, Davies, Faith, Bird, Jennifer

Volltext

Treatment Patterns & Survival In Multiple Myeloma Patients Sequentially Exposed To Thalidomide, Bortezomib & Lenalidomide In a UK Single Centre von Tarant, Julie L, Ashcroft, John, Feyler, Sylvia, Owen, Roger G, Parrish, Christopher, Cook, Gordon

Volltext

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results von Jackson, Graham H., Morgan, Gareth J., Davies, Faith E., Wu, Ping, Gregory, Walter M., Bell, Sue E., Szubert, Alexander J., Navarro Coy, Nuria, Drayson, Mark T., Owen, Roger G., Feyler, Sylvia, Ashcroft, Andrew J., Ross, Fiona M., Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Boyd, Kevin D., Osborne, Wendy L., Cook, Gordon, Child, J. Anthony

Volltext

Lenalidomide Redresses the Effector T Cell:Treg Cell Imbalance in Patients with Multiple Myeloma von Carter, Clive R, Parrish, Christopher, Feyler, Sylvia, Smalle, Natuley, Scott, Gina B, Kallmeyer, Charlotte, Wood, Philip, Cook, Gordon

Volltext

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked von von Lilienfeld-Toal, Marie, Frank, Susanne, Leyendecker, Christiane, Feyler, Sylvia, Jarmin, Sarah, Morgan, Ruth, Glasmacher, Axel, Märten, Angela, Schmidt-Wolf, Ingo G. H, Brossart, Peter, Cook, Gordon

Volltext

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients von Carter, Clive R., Feyler, Sylvia, Smalle, Natuley, Scott, Gina B., Parrish, Christopher, Cullen, Katherine, Kallmeyer, Charlotte, Wood, Philip M., Cook, Gordon

Volltext